Clinical

Dataset Information

0

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma


ABSTRACT: This phase I trial studies the side effects and best dose of MORAb-004 in treating young patients with recurrent or refractory solid tumors or lymphoma. Monoclonal antibodies, such as MORAb-004, can block cancer growth in different ways. Some block the ability of cancer to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them

DISEASE(S): Recurrent Childhood Small Noncleaved Cell Lymphoma,Extranodal Marginal Zone B-cell Lymphoma Of Mucosa-associated Lymphoid Tissue,Lymphoma, Large B-cell, Diffuse,Lymphoma, Large-cell, Immunoblastic,Lymphoproliferative Disorders,Recurrent Childhood Anaplastic Large Cell Lymphoma,Small Intestine Lymphoma,Neoplasms,Childhood Burkitt Lymphoma,Recurrent Grade 1 Follicular Lymphoma,Refractory Hairy Cell Leukemia,Sezary Syndrome,T-cell Large Granular Lymphocyte Leukemia,Adult Nasal Type Extranodal Nk/t-cell Lymphoma,Splenic Marginal Zone Lymphoma,Leukemia, Hairy Cell,Childhood Immunoblastic Large Cell Lymphoma,Mycosis Fungoides,Lymphoma, Mantle-cell,Leukemia-lymphoma, Adult T-cell,Recurrent Adult Immunoblastic Large Cell Lymphoma,Recurrent Adult Burkitt Lymphoma,Leukemia, T-cell,Lymphomatoid Granulomatosis,Recurrent Childhood Lymphoblastic Lymphoma,Lymphoma, T-cell, Peripheral,Lymphoma, Extranodal Nk-t-cell,Plasmablastic Lymphoma,Lymphoma, B-cell, Marginal Zone,Burkitt Lymphoma,Recurrent Adult Diffuse Small Cleaved Cell Lymphoma,Post-transplant Lymphoproliferative Disorder,Nodal Marginal Zone B-cell Lymphoma,Childhood Diffuse Large Cell Lymphoma,Recurrent Small Lymphocytic Lymphoma,Lymphoma, T-cell, Cutaneous,Recurrent Marginal Zone Lymphoma,Recurrent Adult Grade Iii Lymphomatoid Granulomatosis,Lymphoma, Follicular,Waldenstrom Macroglobulinemia,Leukemia, Lymphocytic, Chronic, B-cell,Intraocular Lymphoma,Recurrent Mantle Cell Lymphoma,Unspecified Childhood Solid Tumor, Protocol Specific,Recurrent Grade 3 Follicular Lymphoma,Leukemia,Hodgkin Disease,Recurrent Adult Hodgkin Lymphoma,Mycoses,Waldenström Macroglobulinemia,Noncutaneous Extranodal Lymphoma,Recurrent Adult Lymphoblastic Lymphoma,Recurrent Childhood Large Cell Lymphoma,Angioimmunoblastic T-cell Lymphoma,Recurrent Childhood Grade Iii Lymphomatoid Granulomatosis,Unspecified Adult Solid Tumor, Protocol Specific,Leukemia, Large Granular Lymphocytic,Testicular Lymphoma,Lymphoma, Large-cell, Anaplastic,Lymphoma, T-cell,Hepatosplenic T-cell Lymphoma,Immunoblastic Lymphadenopathy,Precursor Cell Lymphoblastic Leukemia-lymphoma,Recurrent Cutaneous T-cell Non-hodgkin Lymphoma,Lymphoma,Childhood Nasal Type Extranodal Nk/t-cell Lymphoma,Recurrent Mycosis Fungoides/sezary Syndrome,Anaplastic Large Cell Lymphoma,Recurrent Adult Diffuse Mixed Cell Lymphoma,Recurrent Grade 2 Follicular Lymphoma,Peripheral T-cell Lymphoma,Recurrent Adult T-cell Leukemia/lymphoma,Lymphoma, Non-hodgkin,Recurrent Adult Diffuse Large Cell Lymphoma,Lymphoma, B-cell,Recurrent/refractory Childhood Hodgkin Lymphoma,Cutaneous B-cell Non-hodgkin Lymphoma

PROVIDER: 2136787 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2046682 | ecrin-mdr-crc
| 2111714 | ecrin-mdr-crc
| 2138358 | ecrin-mdr-crc
| 2059705 | ecrin-mdr-crc
| 2038889 | ecrin-mdr-crc
| 2046658 | ecrin-mdr-crc
| phs001570 | dbGaP
| 2100536 | ecrin-mdr-crc
| 2104623 | ecrin-mdr-crc
2023-09-06 | GSE239433 | GEO